Savara (SVRA) Tax Rate (2017 - 2018)
Savara (SVRA) reported Tax Rate of 19.21% for Q4 2018, down 1858.0% year-over-year from 1.09% in Q4 2017, and down 2293.1% quarter-over-quarter from 0.88% in Q3 2018.
Savara (SVRA) Tax Rate (2017 - 2018) Analysis & Trends
Savara (SVRA) has 2 years of Tax Rate data on file, last reported at 19.21% in Q4 2018.
- Tax Rate for Q4 2018 came in at 19.21%, down 1858.0% year-over-year; the trailing twelve-month figure through Dec 2018 was 3.56% (up 40.0% YoY), and the FY2018 annual result was 10.29%, up 321.0% from the prior year.
- Tax Rate fell to 19.21% in Q4 2018 per SVRA's latest filing, from 0.88% in the prior quarter.
- Over five years, Tax Rate peaked at 14.5% in Q1 2018 and troughed at 19.21% in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -19.21% |
| Dec 31, 2018 | -19.21% |
| Sep 30, 2018 | 0.88% |
| Sep 30, 2018 | 0.88% |
| Jun 30, 2018 | 2.39% |
| Jun 30, 2018 | 2.39% |
| Mar 31, 2018 | 14.50% |
| Mar 31, 2018 | 14.50% |
| Dec 31, 2017 | -0.63% |
| Dec 31, 2017 | -0.63% |
| Sep 30, 2017 | 1.69% |
| Sep 30, 2017 | 1.69% |
| Jun 30, 2017 | 3.93% |
| Jun 30, 2017 | 3.93% |
| Mar 31, 2017 | 4.55% |
| Mar 31, 2017 | 4.55% |